RNF43 and gastric carcinoma: Furthermore, colorectal cancer research revealed that a combination of peptide vaccines and anti-cancer drugs induced upregulation of the Wnt-inhibitor RNF43 [81], and this therapeutic scheme has been proposed for use in patients with gastric carcinomas, too [57].